All News

“Each person living with cancer has a story to tell, but some may choose not to share it because of its personal nature,” writes one survivor. In this piece, she describes how she found a way to give her story words.

The disease, which advanced to his spine and bones, prevented him from appearing onstage for the “Friends” reunion.

From public health professional to a patient with breast cancer, this person details the selfless that an oncology nurse exhibits in her daily life.

A man with breast cancer recalls his introduction to cancer as a child.

As a hard-working mom and administrator, one nurse shows her passion and fight to get the best care for patients with fibrolamellar carcinoma.

A woman with metastatic breast cancer expresses her concerns about COVID-19 restrictions being lifted and shares an idea for those who are immunocompromised to indicate their health status.

An oncologist describes how gifted and compassionate her primary nurse is with the clinical team and with patients with genitourinary and gynecologic cancers.

A patient with metastatic breast cancer credits her oncology nurse’s compassion for giving her the strength to persevere during her cancer journey.

Patients taking checkpoint inhibitors or immunotherapy in combination with other treatments need to be aware of this potential side effect and the associated symptoms.

A pancreatic cancer survivor explains what your priorities in life should truly be.

From a man with late-stage cancer who has matching tattoos with over 400 strangers to a 78-year-old cancer survivor getting his black belt in Taekwondo, here’s what’s happening in the cancer landscape this week.

One expert tells patients to ‘hang tight’ as immunotherapy options are getting better each year.

Some patients with MPN in the UK were not prescribed the correct medications for management of specific diseases, highlighting the need for improvements in cardiovascular and thrombotic risk management.

Even with newer technologies such as mRNA, experts predict it will be a few years before another cancer vaccine is approved.

A woman with stage 4 ovarian cancer discusses the importance of having compassion for other people, because you never know what they may be dealing with.

In this episode of the “CURE® Talks Cancer” podcast, Colin Jackson explains how he was able to complete a marathon even after cancer treatments that called for surgical removal of part of his femur, hip and surrounding muscle.

Novel combo regimen reduces number of toxic treatments in patients with NSCLC.

The combination of Imbruvica with Venclexta significantly reduced the risk for progression or death by 78% compared with chlorambucil plus obinutuzumab.

In an interview with CURE®, a survivor recounts how his experiences with cancer treatment in the 1960s, when he was treated in a segregated “colored” ward, have led him to a life of advocacy work.

“Hiking is a great activity for all of us, including cancer survivors,” writes a breast cancer survivor. “As long as we can put one foot in front of the other, being out on a trail is inspirational and health-affirming.”

BiTE therapy could lead to better ways to target the immune system, while minimizing the chance of resistance.

Reaching a younger age group of African American men for prostate cancer detection may improve their survival outcomes, says an expert from the University of California San Diego.

Treatment with the combination of Stivarga and Bavencio was associated with minor anti-tumor activity in patients with advanced, heavily pretreated biliary tract solid tumors.

Treatment with pyrotinib and the chemotherapies trastuzumab, docetaxel and carboplatin significantly improved response rates over the triplet chemotherapy regimen alone in the neoadjuvant treatment of patients with HER2-positive breast cancer.

A cancer survivor describes how oncology nurses have had a deep impact on her during treatment.

First immunotherapy, intralesional therapy, is making a comeback and producing durable remissions for a subgroup of patients with cancer.

Experts urge patients to stop playing the wait-and-see game: There’s no ‘playbook’ for immunotherapy-related toxicities, and side effects can be managed if caught early.

CNN’s chief international anchor announced her ovarian cancer diagnosis live on-air today, which she wants everyone to use as a call to arms for all people to undergo cancer screening.

To avoid the financial burden of costly therapies, patients with cancer receiving immunotherapy treatments should talk with their health care team and not settle for no as an answer from their health insurance provider, according to an expert.

These findings, according to one of the study’s authors, demonstrate that Yescarta addresses an important unmet medical need for patients with relapsed/refractory follicular lymphoma.